170 related articles for article (PubMed ID: 31898155)
1. Comorbidity and polypharmacy in patients with breast cancer.
Topaloğlu US; Özaslan E
Breast Cancer; 2020 May; 27(3):477-482. PubMed ID: 31898155
[TBL] [Abstract][Full Text] [Related]
2. Polypharmacy and Adherence to Adjuvant Endocrine Therapy for Breast Cancer.
Calip GS; Xing S; Jun DH; Lee WJ; Hoskins KF; Ko NY
J Oncol Pract; 2017 May; 13(5):e451-e462. PubMed ID: 28287854
[TBL] [Abstract][Full Text] [Related]
3. [Effective treatment strategy in elderly breast cancer patients].
Boér K
Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
[TBL] [Abstract][Full Text] [Related]
4. Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients.
Alkan A; Yaşar A; Karcı E; Köksoy EB; Ürün M; Şenler FÇ; Ürün Y; Tuncay G; Ergün H; Akbulut H
Support Care Cancer; 2017 Jan; 25(1):229-236. PubMed ID: 27619388
[TBL] [Abstract][Full Text] [Related]
5. Comorbidity, Polytherapy, and Drug Interactions in a Neurological Context: An Example of a Multidisciplinary Approach to Promote the Rational Use of Drugs.
Busa G; Burlina A; Damuzzo V; Chiumente M; Palozzo AC
J Pharm Pract; 2018 Feb; 31(1):58-65. PubMed ID: 29278992
[TBL] [Abstract][Full Text] [Related]
6. The practice of polypharmacy involving herbal and prescription medicines in the treatment of diabetes mellitus, hypertension and gastrointestinal disorders in Jamaica.
Delgoda R; Ellington C; Barrett S; Gordon N; Clarke N; Younger N
West Indian Med J; 2004 Dec; 53(6):400-5. PubMed ID: 15816268
[TBL] [Abstract][Full Text] [Related]
7. Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: results from the OMEGA study of the Dutch breast cancer trialists' group.
Hamaker ME; Seynaeve C; Wymenga AN; van Tinteren H; Nortier JW; Maartense E; de Graaf H; de Jongh FE; Braun JJ; Los M; Schrama JG; van Leeuwen-Stok AE; de Groot SM; Smorenburg CH
Breast; 2014 Feb; 23(1):81-7. PubMed ID: 24314824
[TBL] [Abstract][Full Text] [Related]
8. Potentially inappropriate medication use in older patients with breast and colorectal cancer.
Karuturi MS; Holmes HM; Lei X; Johnson M; Barcenas CH; Cantor SB; Gallick GE; Bast RC; Giordano SH
Cancer; 2018 Jul; 124(14):3000-3007. PubMed ID: 29689595
[TBL] [Abstract][Full Text] [Related]
9. Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study.
Nobili A; Marengoni A; Tettamanti M; Salerno F; Pasina L; Franchi C; Iorio A; Marcucci M; Corrao S; Licata G; Mannucci PM
Eur J Intern Med; 2011 Dec; 22(6):597-602. PubMed ID: 22075287
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer, placing drug interactions in the spotlight: is polypharmacy the cause of everything?
Domínguez-Alonso JA; Conde-Estévez D; Bosch D; Pi-Figueras M; Tusquets I
Clin Transl Oncol; 2021 Jan; 23(1):65-73. PubMed ID: 32449126
[TBL] [Abstract][Full Text] [Related]
11. Polypharmacy in the Management of Arterial Hypertension-Friend or Foe?
Diaconu CC; Cozma MA; Dobrică EC; Gheorghe G; Jichitu A; Ionescu VA; Nicolae AC; Drăgoi CM; Găman MA
Medicina (Kaunas); 2021 Nov; 57(12):. PubMed ID: 34946233
[No Abstract] [Full Text] [Related]
12. Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH.
Moore HN; Mao L; Oramasionwu CU
AIDS Care; 2015; 27(12):1443-8. PubMed ID: 26608408
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of comorbidity and polypharmacy in middle-aged and elderly patients].
Su BB; Ma JX; Song W; Yuan J; Dong XY; Wan J
Zhonghua Yi Xue Za Zhi; 2020 Jul; 100(25):1983-1987. PubMed ID: 32629601
[No Abstract] [Full Text] [Related]
14. Polypharmacy in elderly hospitalised patients in Slovakia.
Wawruch M; Zikavska M; Wsolova L; Kuzelova M; Tisonova J; Gajdosik J; Urbanek K; Kristova V
Pharm World Sci; 2008 Jun; 30(3):235-42. PubMed ID: 17943457
[TBL] [Abstract][Full Text] [Related]
15. Polypharmacy among patients with diabetes: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia.
Alwhaibi M; Balkhi B; Alhawassi TM; Alkofide H; Alduhaim N; Alabdulali R; Drweesh H; Sambamoorthi U
BMJ Open; 2018 May; 8(5):e020852. PubMed ID: 29794097
[TBL] [Abstract][Full Text] [Related]
16. Co-morbidity and clinically significant interactions between antiepileptic drugs and other drugs in elderly patients with newly diagnosed epilepsy.
Bruun E; Virta LJ; Kälviäinen R; Keränen T
Epilepsy Behav; 2017 Aug; 73():71-76. PubMed ID: 28622547
[TBL] [Abstract][Full Text] [Related]
17. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.
Sokol KC; Knudsen JF; Li MM
J Clin Pharm Ther; 2007 Apr; 32(2):169-75. PubMed ID: 17381667
[TBL] [Abstract][Full Text] [Related]
18. Comorbidities and co-medications in populations with and without chronic hepatitis C virus infection in Japan between 2015 and 2016.
Ruzicka DJ; Tetsuka J; Fujimoto G; Kanto T
BMC Infect Dis; 2018 May; 18(1):237. PubMed ID: 29793436
[TBL] [Abstract][Full Text] [Related]
19. Medication regimen complexity in patients with uncontrolled hypertension and/or diabetes.
Rettig SM; Wood Y; Hirsch JD
J Am Pharm Assoc (2003); 2013; 53(4):427-31. PubMed ID: 23892818
[TBL] [Abstract][Full Text] [Related]
20. Polypharmacy in Patients with Ovarian Cancer.
Oldak S; Ioannou S; Kamath P; Huang M; George S; Slomovitz B; Schlumbrecht M
Oncologist; 2019 Sep; 24(9):1201-1208. PubMed ID: 30952819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
